文献速递冠心病外科

慢性肾病、贫血与糖尿病在冠脉搭桥手术中的预后交互作用

Prognostic Interplay of Chronic Kidney Disease, Anemia, and Diabetes in Coronary Bypass Surgery.
PubMed 文献 · Ann Thorac Surg · 2020-06-17

这项回顾性研究纳入1180例冠脉搭桥患者,随访8.6±4.2年,发现慢性肾病、贫血和糖尿病均为死亡的独立预测因素,且合并症越多死亡风险越高,糖尿病会进一步放大风险。

要点

  • 慢性肾病和贫血单独或共同显著增加冠脉搭桥术后远期死亡风险。
  • 慢性肾病合并贫血者死亡风险最高,调整后HR为2.69。
  • 糖尿病在各风险分层中均进一步升高死亡风险。

核心结论

  • 冠脉搭桥患者中贫血和慢性肾病对远期死亡有显著预后影响,其效应与糖尿病的不良影响呈累积关联。

研究设计与样本

  • 回顾性研究纳入1180例接受冠脉搭桥手术的患者,平均随访8.6±4.2年,分析术前贫血、慢性肾病和糖尿病与远期死亡的关系。

主要发现

  • 慢性肾病、贫血和糖尿病分别占20%、25%和43%,均为死亡的独立风险预测因素。
  • 与既无慢性肾病也无贫血者相比,仅慢性肾病者调整后HR为1.87(95%CI 1.35-2.59),仅贫血者HR为1.75(95%CI 1.30-2.35),两者兼有者HR为2.69(95%CI 1.91-3.78)。
  • 慢性肾病和贫血与死亡关联的模式在有无糖尿病患者中相似,但糖尿病者在各风险类别中死亡风险均更高。
  • 无慢性肾病且无贫血者中,糖尿病者HR为1.69(95%CI 1.20-2.39)对比参照HR为1;仅慢性肾病者中,糖尿病者HR为2.68(95%CI 1.59-4.52)对比无糖尿病者HR为2.10(95%CI 1.38-3.20)。
  • 仅贫血者中,糖尿病者HR为2.73(95%CI 1.83-4.07)对比无糖尿病者HR为1.94(95%CI 1.23-3.08);慢性肾病合并贫血者中,糖尿病者HR为4.44(95%CI 2.88-6.85)对比无糖尿病者HR为2.72(95%CI 1.58-4.69)。

临床怎么用

  • 冠脉搭桥术前应评估慢性肾病、贫血和糖尿病,合并者需加强远期风险管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease and anemia often coexist and may accompany diabetes; all 3 conditions are associated with worse cardiovascular outcomes. This study investigated the prognostic implications of anemia and chronic kidney disease for mortality among patients undergoing coronary artery-bypass grafting surgery and examined whether outcomes are related to the presence of diabetes. METHODS: This retrospective study included 1180 patients undergoing coronary artery-bypass grafting. Long-term mortality (mean follow-up, 8.6 ± 4.2 years) was examined in relation to preoperative anemia, chronic kidney disease, and diabetes. Prognostic interplay of the 3 risk factors was evaluated. RESULTS: Chronic kidney disease, anemia, and diabetes (20%, 25%, and 43% of patients, respectively), were independent risk predictors for mortality. Compared with patients with neither chronic kidney disease nor anemia, the adjusted hazard ratios (HRs) for mortality were 1.87 (95% confidence interval [CI], 1.35 to 2.59) in chronic kidney disease only, 1.75 (95% CI, 1.30 to 2.35) in anemia only, and 2.69 (95% CI, 1.91 to 3.78) in patients with both conditions. The pattern of association of chronic kidney disease and anemia with mortality was similar in patients with and without diabetes. However, mortality risk was higher in patients with diabetes in each risk category-neither chronic kidney disease nor anemia: HR, 1.69 (95% CI, 1.20 to 2.39) vs HR, 1 (reference); chronic kidney disease only: HR, 2.68 (95% CI, 1.59 to 4.52) vs HR, 2.10 (95% CI, 1.38 to 3.20); anemia only: HR, 2.73 (95% CI, 1.83 to 4.07) vs HR, 1.94 (95% CI, 1.23 to 3.08); and both chronic kidney disease and anemia: HR, 4.44 (95% CI, 2.88 to 6.85) vs HR, 2.72 (95% CI, 1.58 to 4.69). CONCLUSIONS: In patients undergoing coronary artery-bypass grafting, anemia and chronic kidney disease have significant prognostic implications for long-term mortality. Their effect on mortality was cumulatively associated with adverse impacts of diabetes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Zafrir B, Leviner DB, Saliba W, et al. Prognostic Interplay of Chronic Kidney Disease, Anemia, and Diabetes in Coronary Bypass Surgery. Ann Thorac Surg. 2020. PMID: 32561312. doi:10.1016/j.athoracsur.2020.04.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。